Polydex Pharm

Americas

Toronto

Canada

Established

FOUNDED

1966

HEADCOUNT

FUNDING

Public

Keywords:

fermentation, bacteria, biopolymers, therapeutics

Company Website

LinkedIn Page

BUSINESS

Polydex Pharmaceuticals Limited manufactures and distributes dextran and dextran-derivative products to pharmaceutical companies worldwide. Manufacturing is carried out through its subsidiary Dextran Products Limited at a Toronto fermentation plant. The company trades on the US OTC market (POLXF) and was reporting financials through at least 2023.

BIOTECH INVOLVEMENT

Core; produces dextran and derivatives (including iron dextran) via bacterial fermentation of sucrose.

TECHNOLOGY PLATFORM

bacterial dextran fermentation

PRIMARY PRODUCTS

dextran; dextran derivatives (incl. dextran sulfate, iron dextran)